14.94

3.03% 0.44

Bausch Lomb Corp (BLCO)

Overview News Price History Option Chain Financials Discussions Forecast

Bausch Lomb Corp stock is traded at $14.94, with a volume of 935.44K. It is up +3.03% in the last 24 hours and up +4.48% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Previous Close:

$14.50

Open:

$14.63

24h Volume:

935.44K

Relative Volume:

1.23

Market Cap:

$5.29B

Revenue:

$4.79B

Net Income/Loss:

$-317.00M

P/E Ratio:

-16.42

EPS:

-0.91

Net Cash Flow:

$-59.00M

1W Performance:

+2.68%

1M Performance:

+4.48%

6M Performance:

-5.14%

1Y Performance:

-6.57%

1-Day Range:

$14.58

$15.04

1-Week Range:

$14.24

$15.04

52-Week Range:

$10.45

$21.69

Bausch Lomb Corp Stock (BLCO) Company Profile

Name

Bausch Lomb Corp

Sector

Healthcare (1157)

Industry

Medical Instruments & Supplies (58)

Phone

908-541-5456

Address

520 APPLEWOOD CRESCENT, VAUGHAN

Employee

13,500

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

BLCO's Discussions on Twitter

Compare BLCO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BLCO Bausch Lomb Corp	14.94	5.12B	4.79B	-317.00M	-59.00M	-0.91
ISRG Intuitive Surgical Inc	476.16	172.53B	9.15B	2.63B	1.99B	7.17
BDX Becton Dickinson Co	199.66	55.89B	21.39B	1.61B	2.55B	5.56
ALC Alcon Inc	82.02	43.59B	9.93B	1.12B	1.43B	2.26
RMD Resmed Inc	293.73	41.89B	5.15B	1.40B	1.65B	9.51
WST West Pharmaceutical Services Inc	247.85	17.48B	2.96B	487.70M	344.00M	6.68

Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-02-25	Reiterated	H.C. Wainwright	Buy
Mar-28-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-11-24	Downgrade	Citigroup	Buy → Neutral
Dec-02-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-15-24	Upgrade	Evercore ISI	In-line → Outperform
Jul-10-24	Initiated	Raymond James	Outperform
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line
Dec-12-23	Initiated	Stifel	Hold
Oct-03-23	Resumed	Evercore ISI	Outperform
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight
Sep-12-22	Initiated	H.C. Wainwright	Buy
Jul-26-22	Initiated	RBC Capital Mkts	Outperform
Jun-24-22	Initiated	Evercore ISI	Outperform
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Deutsche Bank	Hold
May-31-22	Initiated	Goldman	Neutral
May-31-22	Initiated	Guggenheim	Buy
May-31-22	Initiated	JP Morgan	Neutral
May-31-22	Initiated	Jefferies	Buy
May-31-22	Initiated	Morgan Stanley	Equal-Weight
May-31-22	Initiated	Wells Fargo	Overweight
May-11-22	Initiated	Cowen	Outperform

View All

Bausch Lomb Corp Stock (BLCO) Latest News

Aug 19, 2025

Can technical indicators confirm Bausch + Lomb Corporation’s reversalQuarterly Earnings Report & Technical Entry and Exit Alerts - Newser

Aug 19, 2025

Centuri Holdings, Inc. shares fall 1.39% intraday as Bausch + Lomb Corp terminates agreement with Carl Icahn. - AInvest

Aug 19, 2025

Is it time to cut losses on Bausch + Lomb Corporation2025 Key Lessons & Safe Entry Trade Signal Reports - Newser

Aug 19, 2025

Bausch + Lomb Announces Board ChangesAugust 18, 2025 - BioSpace

Aug 19, 2025

Aug 18, 2025

Icahn representations resign Bausch + Lomb board after agreement termination - Reuters

Aug 18, 2025

Bausch + Lomb Corp terminates agreement with Carl Icahn - MarketScreener

Aug 18, 2025

Bausch + Lomb board members resign after Icahn agreement ends By Reuters - Investing.com

Aug 18, 2025

Bausch + Lomb board members resign after Icahn agreement ends - Reuters

Aug 18, 2025

Icahn representatives resign from Bausch + Lomb board as agreement ends - Investing.com

Aug 18, 2025

Icahn Group Exits Bausch Boards As Paulson Steps In - Finimize

Aug 18, 2025

Reviewing Bausch + Lomb (NYSE:BLCO) & Co-Diagnostics (NASDAQ:CODX) - Defense World

Aug 18, 2025

Aug 16, 2025

How to build a custom watchlist for Bausch + Lomb CorporationJuly 2025 Patterns & Community Consensus Trade Alerts - Newser

Aug 16, 2025

What machine learning models say about Bausch + Lomb CorporationProduct Launch & Reliable Price Action Trade Plans - Newser

Aug 16, 2025

Is now a turning point for Bausch + Lomb CorporationMarket Activity Report & Real-Time Stock Price Movement Reports - Newser

Aug 16, 2025

Aug 15, 2025

How hedge fund analytics apply to Bausch + Lomb Corporation stockWeekly Volume Report & Daily Price Action Insights - Newser

Aug 15, 2025

Stable Stocks to Watch: Hudson Technologies and Bausch + Lomb Underperform, Intuit Shines - AInvest

Aug 15, 2025

Bausch + Lomb to Participate in Upcoming September 2025 Investor Conferences - BioSpace

Aug 15, 2025

Aug 14, 2025

Eye Care Leader Bausch + Lomb Leadership to Share Strategic Updates at JPM and Morgan Stanley Events - Stock Titan

Aug 14, 2025

Bausch + Lomb to Participate in Upcoming Investor Conferences - Yahoo Finance

Aug 14, 2025

Bausch + Lomb’s SWOT analysis: ophthalmology leader faces spin-off uncertainty - Investing.com

Aug 14, 2025

Aug 13, 2025

Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know - Yahoo Finance

Aug 13, 2025

Aug 12, 2025

How Bausch + Lomb Corporation stock performs during market volatilityLow Float Big Mover Alerts - thegnnews.com

Aug 12, 2025

Aug 11, 2025

TR | OpenAI4o Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $14 - 富途牛牛

Aug 11, 2025

Aug 04, 2025

BofA Securities Maintains Bausch + Lomb Corp.(BLCO.US) With Sell Rating, Raises Target Price to $13 - 富途牛牛

Aug 04, 2025

Bausch + Lomb (NYSE:BLCO) Price Target Raised to $13.00 - Defense World

Aug 04, 2025

Aug 03, 2025

Is it the right time to buy Bausch + Lomb Corporation stockMaximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Bausch + Lomb Corporation (NYSE:BLCO) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 02, 2025

Aug 01, 2025

Bausch + Lomb Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 01, 2025

Jul 31, 2025

Bausch & Lomb Raises Price Target to $16.00 Amid Positive Analyst Sentiment. - AInvest

Jul 31, 2025

H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛

Jul 31, 2025

Bausch + Lomb:HC Wainwright Raises PT to $16, Maintains Buy Rating - AInvest

Jul 31, 2025